Patents

Which came first, the cow or the sheep?

Published in Gene Therapy Weekly, March 7th, 2002

Which came first, the cow or the sheep, i.e., Gene or Dolly' That is one of the questions that will be considered by the U.S. Patent Office in what is shaping up as the ultimate battle over who owns the patent for cloning mammals from nonembryonic cells.

It involves three companies: Geron Corp., which in 1999 acquired Roslin Bio-Med (the commercial arm of the United Kingdom lab where the sheep Dolly was cloned), Advanced Cell Technology, Inc., of Massachusetts which gained notoriety in 2001 by attempting to clone the first human embryo, and Infigen, Inc., an animal-cloning company in Madison, Wisconsin.

The simmering battle heated up when Geron...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry